|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.150 CNY | +0.59% |
|
+1.78% | +0.59% |
| 07-29 | Jointown Pharmaceutical Plans Up to 2.2-Billion-Yuan Factoring | MT |
| 07-16 | Jointown Pharmaceutical's Two Drugs Added to China's Essential Medicines List | MT |
| Market Cap | 25.68B 3.8B 3.3B 3.06B 2.82B 5.32B 363B 5.42B 36.26B 14.2B 180B 14.26B 13.95B 605B | P/E 2026 * |
11x | P/E 2027 * | 10.2x |
|---|---|---|---|---|---|
| Enterprise Value | 21.36B 3.16B 2.74B 2.55B 2.35B 4.43B 302B 4.51B 30.16B 11.81B 150B 11.86B 11.6B 504B | EV / Sales 2026 * |
0.13x | EV / Sales 2027 * | 0.11x |
| Free-Float |
43.03% | Yield 2026 * |
4.06% | Yield 2027 * | 4.33% |
| 1 day | +0.59% | ||
| 1 week | +1.78% | ||
| Current month | +9.81% | ||
| 1 month | +7.97% | ||
| 3 months | -0.77% | ||
| 6 months | -5.16% | ||
| Current year | +0.59% |
| 1 week | 4.95 |  | 5.16 |
| 1 month | 4.55 | | 5.28 |
| Current year | 4.48 | | 5.84 |
| 1 year | 4.48 | | 5.84 |
| 3 years | 4.35 | | 6.94 |
| 5 years | 3.97 | | 6.94 |
| 10 years | 3.97 | | 8.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Hua Gong
CEO | Chief Executive Officer | 48 | 14/10/2024 |
Xiao Yi Xia
DFI | Director of Finance/CFO | 48 | 14/11/2023 |
Wei He
CEO | Chief Executive Officer | 40 | 22/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhao Nian Liu
BRD | Director/Board Member | 66 | 15/11/2008 |
Deng Pan Liu
BRD | Director/Board Member | 48 | 04/11/2020 |
Yi Hua Gong
BRD | Director/Board Member | 48 | 30/06/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/06/24 | Buy | Chief Executive Officer | 60,494 | 0.0015% | ||
| 07/06/24 | Buy | 3,025 | 0.0001% | |||
| 07/06/24 | Buy | Director | 1,210 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.59% | +1.78% | -4.81% | -6.90% | 3.8B | |
| -1.22% | +1.61% | +23.20% | +112.33% | 101B | |
| +0.57% | +0.03% | +46.95% | +149.37% | 53.18B | |
| -0.68% | +2.44% | +0.34% | +274.52% | 23.87B | |
| +0.96% | +0.06% | -12.34% | -18.96% | 8.32B | |
| +0.82% | -2.96% | -34.29% | -35.47% | 7.65B | |
| -1.53% | +2.66% | -11.42% | -26.04% | 7.02B | |
| -1.26% | -1.57% | +20.38% | +23.17% | 6.23B | |
| -0.83% | +0.12% | +0.46% | +23.82% | 5.41B | |
| -3.96% | +1.02% | +15.25% | +20.00% | 3.85B | |
| Average | -0.65% | +2.34% | +4.37% | +51.59% | 22.07B | |
| Weighted average by Cap. | -0.62% | +5.74% | +20.76% | +115.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 170B 25.11B 21.81B 20.25B 18.68B 35.18B 2,397B 35.82B 240B 93.87B 1,190B 94.28B 92.22B 4,003B | 180B 26.59B 23.1B 21.45B 19.78B 37.26B 2,538B 37.93B 254B 99.41B 1,261B 99.85B 97.66B 4,240B |
| Net income | 2.36B 348M 303M 281M 259M 488M 33.26B 497M 3.33B 1.3B 16.52B 1.31B 1.28B 55.54B | 2.56B 378M 329M 305M 281M 530M 36.12B 540M 3.61B 1.41B 17.94B 1.42B 1.39B 60.32B |
| Net Debt | -4.32B -639M -555M -515M -475M -895M -61B -911M -6.1B -2.39B -30.29B -2.4B -2.35B -102B | -5.04B -746M -648M -601M -555M -1.04B -71.19B -1.06B -7.12B -2.79B -35.36B -2.8B -2.74B -119B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | CN¥5.150 | 0.00% | 39,474,520 |
| 30/07/26 | CN¥5.150 | +0.59% | 37,447,008 |
| 29/07/26 | CN¥5.120 | +1.99% | 36,208,510 |
| 28/07/26 | CN¥5.020 | -1.18% | 32,464,890 |
| 27/07/26 | CN¥5.080 | +1.40% | 30,929,066 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600998 Stock
Select your edition
All financial news and data tailored to specific country editions
